{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T08:46:00Z","timestamp":1786869960636,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["11019"],"award-info":[{"award-number":["11019"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022833","name":"Rajiv Gandhi Centre for Biotechnology","doi-asserted-by":"publisher","award":["GAP0334"],"award-info":[{"award-number":["GAP0334"]}],"id":[{"id":"10.13039\/100022833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118561","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:42:58Z","timestamp":1758210178000},"page":"118561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting RUNX3\/PARP1 signaling ameliorates colorectal cancer cachexia"],"prefix":"10.1016","volume":"192","author":[{"given":"Abinash","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki Prasad","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Nirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga Prasad","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2025.118561_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118561_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118561_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2025.118561_bib4","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.biopha.2025.118561_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jcsm.12331","article-title":"LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial","volume":"9","author":"Golan","year":"2018","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the north central cancer treatment group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118561_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2025.118561_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1011156811739","article-title":"Highdose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials","volume":"12","author":"Maltoni","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2025.118561_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib10","first-page":"8066","article-title":"Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models","volume":"14","author":"Morimoto","year":"2017","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cmet.2014.04.002","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle","volume":"19","author":"Pirinen","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118561_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114036","article-title":"Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: the randomized phase 3 LYNK-003 study","volume":"205","author":"Takashima","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2025.118561_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41419-022-04967-7","article-title":"PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells","volume":"13","author":"Qin","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","article-title":"A subset of colorectal cancers with Cross-Sensitivity to olaparib and oxaliplatin","volume":"26","author":"Arena","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118561_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/XCS.0000000000000546","article-title":"PARP1 inhibition and effect on burn Injury-Induced inflammatory response and cardiac function","volume":"236","author":"Wen","year":"2023","journal-title":"J. Am. Coll. Surg."},{"issue":"12","key":"10.1016\/j.biopha.2025.118561_bib16","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/jcp.25851","article-title":"Role of PARP activity in lung cancer-induced cachexia: effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype","volume":"232","author":"Chacon-Cabrera","year":"2017","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118561_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(02)00006-X","article-title":"Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress","volume":"180","author":"Gomes-Marcondes","year":"2002","journal-title":"Cancer Lett."},{"issue":"5547","key":"10.1016\/j.biopha.2025.118561_bib18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biopha.2025.118561_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/cells12050717","article-title":"RUNX3 meets the Ubiquitin-Proteasome system in cancer","volume":"12","author":"Toska","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2025.118561_bib20","first-page":"176","article-title":"Oncogenic RUNX3: a link between p53 deficiency and MYC dysregulation","volume":"43","author":"Date","year":"2020","journal-title":"Mol. Cells"},{"key":"10.1016\/j.biopha.2025.118561_bib21","doi-asserted-by":"crossref","unstructured":"uki Date, Tomoya Ueno, Kosei Ito. p53 deficiency causes Myc dysregulation through a novel TGF\u03b2-facilitated promoter switching mechanism to instigate osteosarcoma development [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5732.","DOI":"10.1158\/1538-7445.AM2022-5732"},{"key":"10.1016\/j.biopha.2025.118561_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2020.07.025","article-title":"JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia","volume":"491","author":"Mulder","year":"2020","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2025.118561_bib23","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153746","article-title":"Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia","volume":"23","author":"Wyart","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2025.118561_bib24","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118561_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep10194","article-title":"Inhibition of STAT3, FAK and src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer","volume":"5","author":"Thakur","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118561_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.429","article-title":"Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway","volume":"5","author":"Trivedi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.118561_bib27","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jcmm.12898","article-title":"Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1\u03b2\/IL-1R1\/MyD88\/NF-\u03baB pathway","volume":"20","author":"Song","year":"2016","journal-title":"J. Cell Mol. Med."},{"issue":"41","key":"10.1016\/j.biopha.2025.118561_bib28","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.18632\/oncotarget.27759","article-title":"Evaluation of cancer-derived myocardial impairments using a mouse model","volume":"11","author":"Miyagawa","year":"2020","journal-title":"Oncotarget"},{"issue":"38","key":"10.1016\/j.biopha.2025.118561_bib29","doi-asserted-by":"crossref","first-page":"41146","DOI":"10.18632\/oncotarget.5843","article-title":"Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth","volume":"6","author":"Shukla","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2025.118561_bib30","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/jcp.25851","article-title":"Role of PARP activity in lung cancer-induced cachexia: effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype","volume":"232","author":"Chacon-Cabrera","year":"2017","journal-title":"J. Cell Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118561_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134227","article-title":"Differentiation-Associated downregulation of Poly(ADP-Ribose) Polymerase-1 expression in myoblasts serves to increase their resistance to oxidative stress","volume":"10","author":"Ol\u00e1h","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118561_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72155-8","article-title":"Poly(ADP-ribose) polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation","volume":"10","author":"Matteini","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118561_bib33","article-title":"Human PARP1 substrates and regulators of its catalytic activity: an updated overview","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118561_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41418-019-0379-5","article-title":"RUNX3 suppresses metastasis and stemness by inhibiting hedgehog signaling in colorectal cancer","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib35","first-page":"1991","article-title":"RUNX3 plays an important role in mediating the BMP9-induced osteogenic differentiation of mesenchymal stem cells","volume":"40","author":"Wang","year":"2017","journal-title":"Int. J. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118561_bib36","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/s41598-017-01788-z","article-title":"Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ treg cells","volume":"7","author":"Chakraborty","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib37","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.mam.2012.12.010","article-title":"Poly(ADP-ribose): PARadigms and PARadoxes","volume":"34","author":"B\u00fcrkle","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118561_bib38","first-page":"328","article-title":"PARP-1 and PARP-2: new players in tumour development","volume":"1","author":"Yelamos","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118561_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217444","article-title":"Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model","volume":"611","author":"Khatri","year":"2025","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2025.118561_bib40","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001759R","article-title":"SMURF2-mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells","volume":"35","author":"Ili\u0107","year":"2021","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.biopha.2025.118561_bib41","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/cells12081122","article-title":"p53 Deficiency-Dependent oncogenicity of Runx3","volume":"12","author":"Ito","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2025.118561_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/0008-5472.CAN-17-1178","article-title":"TGF\u03b2 promotes genomic instability after loss of RUNX3","volume":"78","author":"Krishnan","year":"2018","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2025.118561_bib43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.celrep.2018.07.038","article-title":"RUNX Poly(ADP-Ribosyl)ation and BLM interaction facilitate the fanconi anemia pathway of DNA repair","volume":"24","author":"Tay","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118561_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5483\/BMBRep.2018.51.4.033","article-title":"Emerging role of RUNX3 in the regulation of tumor microenvironment","volume":"51","author":"Manandhar","year":"2018","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118561_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-1119(01)00760-0","article-title":"The RUNX3 gene--sequence, structure and regulated expression","volume":"279","author":"Bangsow","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2025.118561_bib46","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/s41467-019-09810-w","article-title":"RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point","volume":"10","author":"Lee","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2025.118561_bib47","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/cells12050708","article-title":"Role of RUNX3 in restriction point regulation","volume":"12","author":"Lee","year":"2023","journal-title":"Cells"},{"issue":"28","key":"10.1016\/j.biopha.2025.118561_bib48","doi-asserted-by":"crossref","first-page":"29409","DOI":"10.1074\/jbc.M313120200","article-title":"Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation","volume":"279","author":"Jin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2025.118561_bib49","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1074\/jbc.M804659200","article-title":"Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of smad proteins","volume":"284","author":"Nakano","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.biopha.2025.118561_bib50","doi-asserted-by":"crossref","first-page":"31577","DOI":"10.1074\/jbc.274.44.31577","article-title":"Interaction and functional cooperation of PEBP2\/CBF with smads. Synergistic induction of the immunoglobulin germline Calpha promoter","volume":"274","author":"Hanai","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118561_bib51","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.cell.2015.04.048","article-title":"RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma","volume":"161","author":"Whittle","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118561_bib52","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/nar\/gkac1235","article-title":"Influence of chain length and branching on poly(ADP-ribose)-protein interactions","volume":"51","author":"L\u00f6ffler","year":"2023","journal-title":"Nucleic Acids Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:47:54Z","timestamp":1775782074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"alternative-id":["S0753332225007553"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118561","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting RUNX3\/PARP1 signaling ameliorates colorectal cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118561"}}